Abstract:The numerous beneficial health outcomes associated with the use of metformin to treat patients with type 2 diabetes (T2DM), together with data from pre-clinical studies in animals including the nematode, C. elegans, and mice have prompted investigations into whether metformin has therapeutic utility as an anti-aging drug that may also extend lifespan. Indeed, clinical trials, including the MILES (Metformin In Longevity Study) and TAME (Targeting Aging with Metformin), have been designed to assess the potential benefits of metformin as an anti-aging drug. Preliminary analysis of results from MILES indicate that metformin may induce anti-aging transcriptional changes; however it remains controversial as to whether metformin is protective in those subjects free of disease. Furthermore, despite clinical use for over 60 years as an anti-diabetic drug, the cellular mechanisms by which metformin exerts either its actions remain unclear. In this review, we have critically evaluated the literature that has investigated the effects of metformin on aging, healthspan and lifespan in humans as well as other species. In preparing this review, particular attention has been placed on the strength and reproducibility of data and quality of the study protocols with respect to the pharmacokinetic and pharmacodynamic properties of metformin. We conclude that despite data in support of anti-aging benefits, the evidence that metformin increases lifespan remains controversial. However, via its ability to reduce early mortality associated with various diseases, including diabetes, cardiovascular disease, cognitive decline and cancer, metformin can improve healthspan thereby extending the period of life spent in good health. Based on the available evidence we conclude that the beneficial effects of metformin on aging and healthspan are primarily indirect via its effects on cellular metabolism and result from its anti-hyperglycemic action, enhancing insulin sensitivity, reduction of oxidative stress and protective effects on the endothelium and vascular function.

The anti-aging role of metformin, clinical applications to pursue the longevity road

A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan

Metformin: From diabetes to cancer to prolongation of life

Metformin in aging and aging-related diseases: clinical applications and relevant mechanisms

Repurposing metformin: an old drug with new tricks in its binding pockets

The direct targets of metformin in diabetes and beyond

Τhe Endless Beauty of Metformin: Does It Also Protect from Skin Aging? A Narrative Review

Metformin: Sentinel of the Epigenetic Landscapes That Underlie Cell Fate and Identity

228-LB: Metformin Alleviates Aging-Associated Metabolic Disorders through Intestinal AMPK-Mediated Gut Microbiome Alteration

Diverse Applications of the Anti-Diabetic Drug Metformin in Treating Human Disease

New Insight into the Effects of Metformin on Diabetic Retinopathy, Aging and Cancer: Nonapoptotic Cell Death, Immunosuppression, and Effects beyond the AMPK Pathway

Metformin: An Old Drug with New Applications

Immunomodulatory and Antiaging Mechanisms of Resveratrol, Rapamycin, and Metformin: Focus on mTOR and AMPK Signaling Networks

Metformin: a metabolic modulator

Metformin beyond type 2 diabetes: Emerging and potential new indications

A New Role for an Old Drug: Metformin Targets MicroRNAs in Treating Diabetes and Cancer

Expanding the therapeutic spectrum of metformin: from diabetes to cancer

The Current and Potential Therapeutic Use of Metformin-The Good Old Drug

Cellular and molecular mechanisms of metformin: an overview

The Development and Benefits of Metformin in Various Diseases.

Repurposing effect of cardiovascular-metabolic drug to increase lifespan: a systematic review of animal studies and current clinical trial progress